Janux Therapeutics Stock Forecast

Stock Price Forecast

The 11 analysts that cover Janux Therapeutics stock have a consensus rating of "Buy" and an average price target of $48.73, which forecasts a 215.20% increase in the stock price over the next year. The lowest target is $12 and the highest is $100.

Price Target: $48.73 (+215.20%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$12	$48.73	$45	$100
Change	-22.38%	+215.20%	+191.07%	+546.83%

Analyst Ratings

The average analyst rating for Janux Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	4	6	5	5	5	5
Buy	5	4	4	4	4	3
Hold	2	2	3	3	3	3
Sell	0	0	0	0	0	1
Strong Sell	0	0	0	0	0	0
Total	11	12	12	12	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Etzer Darout Barclays	Barclays	Buy → Sell Downgrades $29 → $14	Buy → Sell	Downgrades	$29 → $14	-9.44%	Apr 20, 2026
David Dai UBS	UBS	Strong Buy → Hold Downgrades $57 → $15	Strong Buy → Hold	Downgrades	$57 → $15	-2.98%	Apr 15, 2026
Josh Schimmer Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $150 → $100	Buy	Maintains	$150 → $100	+546.83%	Feb 27, 2026
Brad Canino Guggenheim	Guggenheim	Strong Buy Maintains $72 → $68	Strong Buy	Maintains	$72 → $68	+339.84%	Feb 27, 2026
Kaveri Pohlman Clear Street	Clear Street	Strong Buy → Hold Downgrades $32 → $12	Strong Buy → Hold	Downgrades	$32 → $12	-22.38%	Jan 20, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

9.22M

from 10.00M

-7.81%

from 10.00M

Revenue Next Year

6.68M

from 9.22M

-27.50%

from 9.22M

EPS This Year

-2.60

from -1.83

EPS Next Year

-3.35

from -2.60

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	3.64M	8.61M	8.08M	10.59M	10.00M	9.22M	6.68M
Revenue Growth	-	136.79%	-6.14%	30.99%	-5.55%	-7.81%	-27.50%
EPS	-1.39	-1.52	-1.32	-1.28	-1.83	-2.60	-3.35
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	20	17

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	60.4M	36.8M
Avg	9.2M	6.7M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	503.7%	298.6%
Avg	-7.8%	-27.5%
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.91	-1.73
Avg	-2.60	-3.35
Low	-3.22	-5.84

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.